Astal Laboratories has acquired a Pharmaceutical Intermediates Manufacturing Plant located at KIADB Industrial Growth Center, Raichur, Karnataka of Shree Venus Health Sciences.
The acquisition of the manufacturing facility would lead to increase the capacity of manufacturing of pharmaceutical intermediate (API). Dependency on Supply chain would be reduced due to increased manufacturing capacity of pharmaceutical intermediates. The Addition will Build Capital Asset & Profit Margin also will Increase. Addition will provide the existing customers assured domestic source of supplies. Cost of acquisition is Rs 9.60 crore.
Astal Laboratories is a premier medical research and pharmaceutical Active Pharmaceutical Ingredient (API) developer, committed to transforming scientific discoveries into life-changing therapies.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: